In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Both batches of data will be scrutinised for what they could mean for the European Central ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...

Shares of NYSE GSK opened at $33.43 on Friday. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.81 and a quick ratio of 0.53. GSK has a 1-year low of $32.83 and a 1-year high ...

Previously head of GSK’s consumer health division, Walmsley joined the company in 2010 after spending 17 years at L’Oreal. Witty has been in charge of GSK since 2008 and is paid nearly £1.1 ...

Two 17-year-old males have been arrested in relation to an assault in Mullingar, Co Westmeath, that has left a man in critical condition. Gardaí at Mullingar are continuing to investigate all the ...

PARKLAND, Wash. — The family of a 2-year-old girl killed by her mother's boyfriend is now suing Washington state and the daycare the young girl attended. The lawsuit alleges more could have been ...

“I don’t want to speak about the details of what we discussed during that dinner because I want to respect the privacy, but we developed a good relation ... uptake. GSK’s Arexvy, which ...

GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug ...